Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.
about
Concurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinomaConcurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinomaAn overview of the rare parotid gland cancerA single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancerPhase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma.Past, present, and future of molecular and cellular oncologyHyperfractionated radiotherapy with concurrent cisplatin/5-Fluorouracil for locoregional advanced head and neck cancer: analysis of 105 consecutive patients.Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors.Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.Enteral nutrition support of head and neck cancer patients.Treatment complications and survival in advanced laryngeal cancer: a population-based analysisDefinitive chemoradiation for primary oral cavity carcinoma: A single institution experience.IMRT for head and neck cancer: reducing xerostomia and dysphagia.Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience.Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck.Head and neck cancer: an evolving treatment paradigm.A Comparative Study on Weekly Versus Three Weekly Cisplatinum Based Chemoradiation in Locally Advanced Head and Neck Cancers.The metabolic switch and its regulation in cancer cells.Organ-sparing radiation therapy for head and neck cancer.Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly.Organ preservation strategies: Review of literature and their applicability in developing nations.Trial Watch: Anticancer radioimmunotherapy.Trial Watch: Radioimmunotherapy for oncological indications.A clinical trial of multiple peptides vaccination for advanced head and neck cancer patients induced immune responses and prolonged OS.The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma.When is surgical therapy for head and neck malignant epithelial tumors not indicated?Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.The Effect of Head and Neck Radiotherapy on Blood Pressure and Orthostatic Hypotension in Patients With Head and Neck Tumors.Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.Comparative Study of Superselective Intra-Arterial Chemoradiotherapy versus Radical Surgery on Distant Metastasis for Advanced Oral Cancer
P2860
Q24186289-B94E6266-3DF6-4944-AF5C-791844EE485FQ24201507-E8EC6A7A-CB14-4644-A951-E7B81328845FQ26824989-119E9FA0-E53B-4A52-BA8C-45205E099103Q34498577-6EECF27B-EC97-46D5-9365-3A0421DB3E3EQ35553791-232A587F-54EC-4132-A304-C3A391554D2AQ35972276-0C983ECC-7757-46C2-8ABB-600F40DF609FQ36072454-A240A5D9-3BD5-42D2-B527-E74EA3045917Q36116471-245A2D1E-A025-49FD-928D-B5A0F4AEBA13Q36524522-334D259D-D053-4F65-989F-A4E6C05286D4Q36715124-B3E21209-9B2C-408A-9BDA-CB621FEC0390Q36766930-DD695EC2-B14C-445C-8DE8-4576872FCFD6Q37156582-5A33CAD4-DC85-4E7A-B1F8-5CEE6D2B138CQ37187245-CBA37DBB-43D4-446C-A0D7-67C27FC66DE7Q37242570-8B261222-3B43-4F1B-A605-9673F3822ABFQ37245384-CDCB00C8-A0F1-426C-968A-2C42A36AFFBDQ37271937-5674ED77-D7DF-48CB-BF8A-F2B8D0ED6A2FQ37663737-77FBFF08-0469-4192-B6C5-40DBFC1F4724Q37785870-46F9AFAF-74C9-49CC-9F41-93B118367451Q37905536-4FBB7D04-AECD-44A4-B3E2-AC0E00DE3A1BQ37948702-5C9D154D-232D-4F2C-A8DA-05C332553702Q38241209-164F8619-7D61-4AD5-ACBB-9B7811127E09Q42847992-F46FE333-FEAF-44C4-895F-00B5F198F6B1Q43104064-FBE9EBD6-B4D6-4038-B605-66B880AA63B4Q43245237-A652C89E-A995-49DE-A1D9-A08E3C5B4348Q47289028-0EBBF519-C3EB-4F5F-B2AA-A58598A980B7Q48086799-E8D4E62C-0C10-4F92-BD4E-368D20933C13Q48717787-FF032067-E7B7-4490-AF1A-A9035058D2ACQ49556727-2618FDB2-3701-4F51-B32B-C2F75EA92D19Q53090717-5F8918FC-22A8-440E-8FC6-43F0D56BC115Q59048840-12B3B292-0F96-472E-84AD-CCA897E4B1DC
P2860
Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Concurrent chemoradiotherapy f ...... s, controversy, and conundrum.
@ast
Concurrent chemoradiotherapy f ...... s, controversy, and conundrum.
@en
type
label
Concurrent chemoradiotherapy f ...... s, controversy, and conundrum.
@ast
Concurrent chemoradiotherapy f ...... s, controversy, and conundrum.
@en
prefLabel
Concurrent chemoradiotherapy f ...... s, controversy, and conundrum.
@ast
Concurrent chemoradiotherapy f ...... s, controversy, and conundrum.
@en
P356
P1476
Concurrent chemoradiotherapy f ...... s, controversy, and conundrum.
@en
P2093
David M Brizel
Ramon Esclamado
P304
P356
10.1200/JCO.2005.05.2829
P407
P577
2006-06-01T00:00:00Z